fabry2009

12/16

2758) Miyata M, Kihara T, Kubozono T, Ikeda Y, Shinsato T, Izumi T, Matsuzaki M, Yamaguchi T, Kasanuki H, Daida H, Nagayama M, Nishigami K, Hirata K, Kihara K, Tei C. Benefi cial eff ects of Waon therapy on patients with chronic heart failure: Results of a prospective multicenter study. J Cardiol. 2008; 52: 79-85. 59) Shah JS, Hughes DA, Sachdev B, Tome M, Ward D, Lee P, Mehta AB, Elliott PM. Prevalence and clinical signifi cance of cardiac arrhythmia in Anderson-Fabry disease. Am J Cardiol. 2005; 96: 842-846.60) Cantor WJ, Daly P, Iwanochko M, Clarke JT, Cusimano RJ, Butany J. Cardiac transplantation for Fabry’s disease. Can J Cardiol. 1998; 14: 81-84.61) Igawa O, Miake J, Hisatome I. Ventricular tachycardias and dilated cardiomyopathy caused by Fabry disease. Pace. 2005; 28: 1142-1143.62) Chimenti C, Morgante E, Critelli G, Russo MA, Frustaci A. Coronary artery bypass grafting for Fabry’s disease: veins more suitable than arteries? Hum Pathol. 2007; 38: 1864-1867.63) Tahir H, et al. Antiproteinuric Therapy and Fabry Nephropathy: Sustained Reduction of Proteinuria in Patients Receiving Enzyme Replacement Therapy with Agalsidase-B. J Am Soc Nephrol. 2007; 18: 2609-2617.

※このページを正しく表示するにはFlashPlayer9以上が必要です